Search results
Sanofi (SNY) Stock Outperforms Industry YTD: What's Next?
Zacks via Yahoo Finance· 8 months agoContinued strong sales of Dupixent, contributions from new product launches and positive pipeline...
Sanofi (SNY) Q1 Earnings In Line, Sales Miss Estimates, Stock Up
Zacks via Yahoo Finance· 2 months agoSanofi SNY reported first-quarter 2024 adjusted earnings of 96 cents per American depositary share,...
Top Stock Reports for Amazon.com, Sanofi & Target
Zacks via Yahoo Finance· 2 years agoFriday, November 11, 2022 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research...
Sanofi (SNY) Misses on Q4 Earnings and Sales, Stock Down
Zacks via Yahoo Finance· 5 months agoSanofi SNY reported fourth-quarter 2023 adjusted earnings of 89 cents per American depositary share,...
Sanofi (SNY) to Report Q3 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 years agoSanofi SNY will report third-quarter 2022 results on Oct 28 before market open. In the last reported...
Will Sanofi (SNY) Surpass Estimates This Earnings Season?
Zacks via Yahoo Finance· 1 year agoWe expect Sanofi SNY to beat expectations when it reports first-quarter 2023 results on Apr 27,...
Sanofi (SNY) Terminates Pompe Disease Deal as FTC Objects
Zacks via Yahoo Finance· 6 months agoSanofi (SNY) decides to end the licensing deal with Maze Therapeutics for MZE001, a phase II ready...
Sanofi (SNY) Q2 Earnings & Sales Beat, Ups 2022 Growth View
Zacks via Yahoo Finance· 2 years agoSanofi (SNY) beats second-quarter estimates for earnings and sales. Dupixent drives sales growth and...
Sanofi (SNY) Q1 Earnings Beat, Sales Miss, Dupixent Strong
Zacks via Yahoo Finance· 1 year agoSanofi (SNY) beats first-quarter estimates for earnings but misses the same for sales. Higher sales...
Sanofi's (SNY) Studies on BTK Inhibitor Put on Hold by FDA
Zacks via Yahoo Finance· 2 years agoSanofi (SNY) pauses enrollment in late-stage studies evaluating its BTK inhibitor in multiple...